It has been demonstrated that hypoxia alters the levels of immune checkpoints like CTLA-4, PD-1/L-1, CD47, and TIM3 to modify the immune cell-induced anti-tumor response, thus suppressing immune surveillance [64]. This evidence concerns the gene CTLA4 and neoplasm.